Syndax Pharmaceuticals In... (SNDX)
14.21
-0.03 (-0.21%)
At close: Jan 30, 2025, 3:59 PM
14.21
0.00%
After-hours Jan 30, 2025, 04:00 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Cash & Equivalents | 295.39M | 74.36M | 221.97M | 115.24M | 24.61M | 33.77M | 35.17M | 23.84M | 23.18M | 10.01M | 10.10M | 537.00K | 3.70M |
| Short-Term Investments | 282.19M | 410.04M | 217.97M | 177.82M | 35.17M | 47.14M | 94.81M | 81.49M | 64.11M | 2.20M | 4.16M | 91.00K | 613.00K |
| Long-Term Investments | 29.83M | 5.47M | n/a | 115.00K | 115.00K | n/a | 3.25M | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 680.00K | 9.44M | n/a | 1.15M | 82.00K | 219.00K | 231.00K | 243.00K | 1.81M | 339.00K | 2.48M | 755.00K | 345.00K |
| Receivables | 1.23M | 4.06M | 429.00K | 175.00K | 116.00K | 253.00K | 377.00K | 306.00K | 258.00K | 35.00K | n/a | n/a | n/a |
| Inventory | n/a | -4.25M | 7.65M | 5.28M | 1.68M | 1.05M | -1.44M | 2.41M | 264.00K | 51.00K | n/a | n/a | n/a |
| Other Current Assets | 2.07M | 9.93M | 7.92M | 5.62M | 2.44M | 2.08M | 2.98M | 2.87M | 1.21M | 150.00K | 280.00K | 107.00K | 77.00K |
| Total Current Assets | 580.88M | 481.27M | 448.40M | 298.86M | 62.33M | 83.35M | 133.44M | 108.51M | 88.01M | 12.44M | 14.54M | 735.00K | 4.39M |
| Property-Plant & Equipment | 1.50M | 1.06M | 1.26M | 482.00K | 997.00K | 373.00K | 267.00K | 260.00K | 88.00K | 33.00K | 40.00K | 20.00K | 50.00K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 32.00M | 15.96M | 1.26M | 1.75M | 1.19M | 592.00K | 3.74M | 503.00K | 1.90M | 372.00K | 2.52M | 775.00K | 395.00K |
| Total Assets | 612.88M | 497.24M | 449.66M | 300.61M | 63.52M | 83.94M | 137.19M | 109.01M | 89.90M | 12.82M | 17.06M | 1.51M | 4.79M |
| Account Payables | 9.96M | 4.35M | 5.67M | 3.51M | 6.18M | 1.44M | 2.23M | 2.38M | 1.45M | 354.00K | 1.08M | 776.00K | 810.00K |
| Deferred Revenue | n/a | n/a | 12.76M | 1.52M | 1.52M | 1.52M | 1.57M | 1.22M | 1.22M | 3.38M | n/a | 2.41M | n/a |
| Short-Term Debt | 1.05M | 439.00K | 362.00K | 2.60M | 478.00K | n/a | n/a | n/a | n/a | 6.45M | n/a | 21.34M | 10.68M |
| Other Current Liabilities | 47.09M | 24.28M | 14.65M | 11.25M | 10.20M | 13.15M | 11.99M | 6.77M | 2.17M | 3.54M | 1.65M | 2.98M | 1.92M |
| Total Current Liabilities | 58.10M | 29.07M | 20.68M | 18.87M | 18.37M | 16.11M | 15.80M | 10.37M | 4.85M | 10.35M | 2.73M | 25.10M | 13.41M |
| Long-Term Debt | 588.00K | 722.00K | 20.61M | 17.93M | 419.00K | n/a | n/a | n/a | n/a | 7.43M | n/a | n/a | 8.66M |
| Other Long-Term Liabilities | n/a | n/a | n/a | 1K | 5.00K | 136.00K | 310.00K | 288.00K | 2.92M | 751.00K | 2.48M | 5.69M | 1.77M |
| Total Long-Term Liabilities | 588.00K | 722.00K | 20.61M | 29.55M | 13.56M | 14.79M | 17.07M | 14.51M | 18.36M | 8.19M | 2.48M | 5.69M | 10.44M |
| Total Liabilities | 58.68M | 29.79M | 41.29M | 48.42M | 31.93M | 30.89M | 32.87M | 24.87M | 23.20M | 18.53M | 5.21M | 30.80M | 23.84M |
| Total Debt | 1.64M | 1.16M | 20.97M | 20.54M | 897.00K | n/a | n/a | n/a | n/a | 13.88M | n/a | 21.34M | 19.34M |
| Common Stock | 8.00K | 7.00K | 6.00K | 5.00K | 3.00K | 2.00K | 2.00K | 2.00K | 1K | 1K | 1K | n/a | n/a |
| Retained Earnings | -902.40M | -693.04M | -543.70M | -568.63M | -495.47M | -439.42M | -366.11M | -305.29M | -259.68M | -159.80M | -135.71M | -79.05M | -68.90M |
| Comprehensive Income | 218.00K | -806.00K | 45.00K | -4.00K | n/a | -25.00K | -143.00K | 56.00K | 28.00K | -185.00K | -170.00K | -238.00K | n/a |
| Shareholders Equity | 554.20M | 467.45M | 408.37M | 252.19M | 31.60M | 53.05M | 104.32M | 84.14M | 66.70M | -5.72M | 11.85M | -29.29M | -19.05M |
| Total Investments | 312.02M | 406.92M | 217.97M | 177.82M | 35.17M | 47.14M | 98.05M | 81.49M | 64.11M | 2.20M | 4.16M | 91.00K | 613.00K |